Since 2001, Gandeepam has been clear in its intention to pursue Randomized Control Clinical Trial (RCT) evaluation of its HIV medicines.
A model for an RCT of Siddha HIV treatment has been designed through dialogue between Gandeepam Siddha medical personnel and the Oxford University GIFTS of Health research team.
|
|